PPT-XOSPATA TM (gilteritinib)
Author : udeline | Published Date : 2022-06-14
monotherapy for the treatment of relapsed or refractory acute myeloid leukaemia AML with a FLT3 mutation 1 XOS20200016IL Date of preparation Nov2020 1 MOH approved
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "XOSPATA TM (gilteritinib)" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
XOSPATA TM (gilteritinib): Transcript
Related Documents